Bortezomib enhances antigen-specific cytotoxic T cell responses against immune-resistant cancer cells generated by STAT3-ablated dendritic cells
Keyword(s):
T Cell
◽
2004 ◽
Vol 101
(43)
◽
pp. 15440-15445
◽